Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Observational × Hearing Loss × Clear all

Status

Sponsor Class

OTHER 10 OTHER_GOV 1 NIH 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 60 Neoplasms 59 Prostatic Neoplasms 32 Colorectal Neoplasms 30 Lung Neoplasms 25 Uterine Cervical Neoplasms 23 Stomach Neoplasms 22 Endometrial Neoplasms 18 Ovarian Neoplasms 17 Carcinoma, Non-Small-Cell Lung 17 Carcinoma, Hepatocellular 16 Urinary Bladder Neoplasms 15 Thyroid Neoplasms 15 Pancreatic Neoplasms 13 Colonic Neoplasms 12 Multiple Myeloma 11 Esophageal Neoplasms 11 Rectal Neoplasms 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Neoplasm Metastasis 9 Gastrointestinal Neoplasms 9 Thyroid Cancer, Papillary 8 Sarcoma 7 Recurrence 7 Polycystic Ovary Syndrome 7 Melanoma 7 Lymphoma 7 Disease 7 Sarcopenia 6 Obesity 6

Interventions

Radiotherapy 1 Drug Therapy 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡